![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1664, 2008-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
DTaP booster vaccine immunogenic in adolescents and adults
Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
No surprises with switch from DT to DTaP vaccine
Reactions Weekly, Vol. 1, Iss. 1140, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Postmarketing support for safety profile of DTaP vaccine
Reactions Weekly, Vol. 1, Iss. 1294, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
DTaP 5 -IPV-Hib Vaccine (Pediacel®)
Pediatric Drugs, Vol. 13, Iss. 6, 2011-12 ,pp. :